Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2014
10/28/2014US8871257 Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
10/28/2014US8871256 Methods and systems for treatment of inflammatory diseases with nitric oxide
10/28/2014US8871254 Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
10/28/2014US8871253 Liposome having inner water phase containing sulfobutyl ether cyclodextrin salt
10/28/2014US8871248 Compositions for treating biofilms and methods for using same
10/28/2014US8871230 Conjugate with target-finding ligand and use thereof
10/28/2014US8871216 Multiple signaling pathways induced by hexvalent, monospecific and bispecific antibodies for enhanced toxicity to B-cell lymphomas and other diseases
10/28/2014US8871206 Anti-human folate receptor beta antibodies and methods of use
10/28/2014US8871191 Use of IL-15 preparations to treat lymphopenia
10/28/2014US8871190 Polymeric pheromone formulation and method of use to calm stress-related behavior in mammals over an extended period of time
10/28/2014US8871189 MMP-targeted therapeutic and/or diagnostic nanocarriers
10/28/2014US8871184 Topical tetracycline compositions
10/23/2014US20140316112 Method of increasing the hydrodynamic volume of polypeptides by attaching to gonadotrophin carboxy terminal peptides
10/23/2014US20140316111 Chemical Reagents for the Activation of Polysaccharides in the Preparation of Conjugate Vaccines
10/23/2014US20140316110 Chemical Reagents for the Activation of Polysaccharides in the Preparation of Conjugate Vaccines
10/23/2014US20140316013 Crosslinked gelatin support and support for controlled release of physiologically active substance using the same
10/23/2014US20140315976 Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells
10/23/2014US20140315960 Prodrugs of non-steroid anti-inflammatory agents (nsaids)
10/23/2014US20140315955 Stimuli responsive adhesive gel for removal of foreign particles from soft tissue
10/23/2014US20140315953 Method and composition for treating migraines
10/23/2014US20140315948 Pharmaceutical Composition and Administrations Thereof
10/23/2014US20140315837 Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
10/23/2014US20140315833 Cocrystalline DHEA Formulations
10/23/2014US20140315826 Polymeric conjugates of c-1 inhibitors
10/23/2014US20140315815 Use of sulfated glycosaminoglycans for improving the bioavailability of factor viii
10/23/2014US20140315795 Compositions and Methods for Selective Delivery of Oligonucleotide Molecules to Cell Types
10/23/2014US20140315786 Use of intracellular enzymes for the release of covalently linked bioactives
10/23/2014US20140315781 Methods of treating fatty liver disease with helminth-derived glycan-containing compounds
10/23/2014US20140315144 Novel dental appliances and methods for their fabrication
10/23/2014US20140314873 Process and composition of a gel for wound disinfection and promotion of healing
10/23/2014US20140314866 Materials and methods for modulating immune responses
10/23/2014US20140314857 Formulations for enhanced bioavailability of zanamivir
10/23/2014US20140314850 Functionalized nanodiamonds as delivery platforms for nucleic acids
10/23/2014US20140314840 Ubiquinol and alpha lipoic acid compositions
10/23/2014US20140314835 Sustained release of antiinfectives
10/23/2014US20140314794 Compositions and methods for the diagnosis and treatment of tumor
10/23/2014US20140314781 Formulation of human antibodies for treating tnf-alpha associated disorders
10/23/2014US20140314780 Compositions Using Antibodies Directed to GPNMB and Uses Thereof
10/23/2014US20140314749 Compositions and methods for diagnosis and treatment of hepatic cancers
10/23/2014US20140314748 Antibody formulations
10/23/2014US20140314742 Endoglin antibodies
10/23/2014US20140314732 Cross-linked compositions
10/23/2014US20140314722 Matrices comprising a modified polysaccharide
10/23/2014US20140314709 Il-2 derivatives polypeptides with agonist activity for therapy of cancer and chronic infections
10/23/2014US20140314704 Treatment of B Cell Lymphomas
10/23/2014US20140314695 Silicone scar treatment preparation
10/23/2014US20140314677 Substituted silaxanthenium red to near-infrared fluorochromes for in vitro and in vivo imaging and detection
10/23/2014US20140314672 Nanoparticle therapeutic agents, their formulations, and methods of their use
10/23/2014US20140314670 Clicked somatostatin conjugated analogs for biological applications
10/23/2014US20140314667 Methods of treating epidermal growth factor deletion mutant viii related disorders
10/23/2014US20140314666 Targeted carriers for drug delivery across the gastrointestinal epithelium
10/23/2014US20140314664 Hydrophobic Molecule-Induced Branched Polymer Aggregates And Their Use
10/23/2014US20140314663 Peptide-mediated delivery of active agents across the blood-brain barrier
10/21/2014US8865887 Method for synthesizing calixarene and/or cyclodextrin copolymers, terpolymers and tetrapolymers, and uses thereof
10/21/2014US8865875 Site-specific attachment of drugs or other agents to engineered antibodies with C-terminal extensions
10/21/2014US8865868 Conjugated proteins with prolonged in vivo efficacy
10/21/2014US8865779 Compounds, compositions, and methods for reducing or eliminating bitter taste
10/21/2014US8865778 Extended release excipient and its use
10/21/2014US8865776 Use of low molecular weight amino alcohols in ophthalmic compositions
10/21/2014US8865681 Use of lipid conjugates in the treatment of diseases or disorders of the eye
10/21/2014US8865659 Compositions for prevention or treatment of Hepatitis C virus containing ginsenoside Rg3 as an active ingredient
10/21/2014US8865652 Method of treating solid cancers with pegylated IL-10
10/21/2014US8865647 Pharmaceutical solution of non covalently bound albumin and acylated insulin
10/21/2014US8865646 Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging
10/21/2014US8865250 Production of pulverulent coating compositions for stable protective coatings for pharmaceutical dosage forms
10/21/2014US8865240 Process for manufacturing chewable dosage forms for drug delivery and products thereof
10/21/2014US8865204 Manufacture of lozenge product with radiofrequency
10/21/2014US8865203 Pharmacokinetics of S-adenosylmethionine formulations
10/21/2014US8865202 Water soluble film for oral administration with instant wettability
10/21/2014US8865200 Sustained release compositions containing progesterone receptor modulators
10/21/2014US8865198 Method for treating a periodontal disease
10/21/2014US8865195 Foaming formulations and cleansing products including silicone polyesters
10/21/2014US8865187 Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract and providing enhanced therapeutic activity
10/21/2014US8865178 Compositions and methods for wound healing
10/21/2014US8865176 Methods and compositions for generating bioactive assemblies of increased complexity and uses
10/21/2014US8865167 Neutralising antibody molecules having specificity for human IL-17
10/21/2014US8865160 Treatment of disease conditions via administration of DNA repair enzyme
10/21/2014US8865151 MetAP-2 inhibitor polymersomes for therapeutic administration
10/21/2014US8865149 Polymeric reagents comprising a ketone or a related functional group
10/21/2014US8865148 Polyesteramide platform for site specific drug delivery
10/21/2014US8865143 Reversely thermo-reversible hydrogel compositions
10/21/2014US8865140 Soap-based liquid wash formulations with enhanced deposition of make-up agents
10/21/2014US8865139 Topical tetracycline compositions
10/21/2014US8865131 Preparation for use in opthalmology and retinal surgery
10/21/2014US8865130 Methods and compositions for diagnostic and therapeutic targeting of COX-2
10/21/2014US8865126 Vitamin-targeted imaging agents
10/16/2014US20140309581 Method for treating chronic wounds with an extracellular polymeric substance solvating system
10/16/2014US20140309578 Biomedical imaging and therapy using red blood cells
10/16/2014US20140309398 Oligomer-corticosteroid conjugates
10/16/2014US20140309315 Carboxymethylcellulose Polyethylene Glycol Compositions for Medical Uses
10/16/2014US20140309314 Polymeric particles for storage and delivery of active agents
10/16/2014US20140309313 Immunocompatible polymers
10/16/2014US20140309312 Synthesis of an iron based magnetic composite material for anticancer drug delivery
10/16/2014US20140309299 Stabilized Pharmaceutical Preparations in Containers Having Limited Perviousness to Water Vapor
10/16/2014US20140309287 Oligonucleotide formulation
10/16/2014US20140309277 Lipids, lipid compositions, and methods of using them
10/16/2014US20140309235 Heterocyclic compounds and their uses
10/16/2014US20140309205 Ceftolozane antibiotic compositions
10/16/2014US20140309204 Steroid hormone products and methods for preparing them
10/16/2014US20140309197 Stabilized pharmaceutical formulations comprising antineoplastic compounds
1 ... 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 ... 1712